Drug targeting to myofibroblasts: Implications for fibrosis and cancer - PubMed (original) (raw)

Review

. 2017 Nov 1:121:101-116.

doi: 10.1016/j.addr.2017.07.010. Epub 2017 Jul 16.

Affiliations

• PMID: 28720422
• DOI: 10.1016/j.addr.2017.07.010

Free article

Review

Drug targeting to myofibroblasts: Implications for fibrosis and cancer

Saleh Yazdani et al. Adv Drug Deliv Rev. 2017.

Free article

Abstract

Myofibroblasts are the key players in extracellular matrix remodeling, a core phenomenon in numerous devastating fibrotic diseases. Not only in organ fibrosis, but also the pivotal role of myofibroblasts in tumor progression, invasion and metastasis has recently been highlighted. Myofibroblast targeting has gained tremendous attention in order to inhibit the progression of incurable fibrotic diseases, or to limit the myofibroblast-induced tumor progression and metastasis. In this review, we outline the origin of myofibroblasts, their general characteristics and functions during fibrosis progression in three major organs: liver, kidneys and lungs as well as in cancer. We will then discuss the state-of-the art drug targeting technologies to myofibroblasts in context of the above-mentioned organs and tumor microenvironment. The overall objective of this review is therefore to advance our understanding in drug targeting to myofibroblasts, and concurrently identify opportunities and challenges for designing new strategies to develop novel diagnostics and therapeutics against fibrosis and cancer.

Keywords: Drug targeting; Fibrosis; Myofibroblast; Tumor microenvironment.

Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

PubMed Disclaimer

Similar articles

• Promising small molecule anti-fibrotic agents: Newly developed or repositioned drugs targeting myofibroblast transdifferentiation.
  Ishikane S, Arioka M, Takahashi-Yanaga F. Ishikane S, et al. Biochem Pharmacol. 2023 Aug;214:115663. doi: 10.1016/j.bcp.2023.115663. Epub 2023 Jun 17. Biochem Pharmacol. 2023. PMID: 37336252 Review.
• The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.
  Affo S, Yu LX, Schwabe RF. Affo S, et al. Annu Rev Pathol. 2017 Jan 24;12:153-186. doi: 10.1146/annurev-pathol-052016-100322. Epub 2016 Dec 5. Annu Rev Pathol. 2017. PMID: 27959632 Free PMC article. Review.
• Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.
  Tschumperlin DJ, Lagares D. Tschumperlin DJ, et al. Pharmacol Ther. 2020 Aug;212:107575. doi: 10.1016/j.pharmthera.2020.107575. Epub 2020 May 11. Pharmacol Ther. 2020. PMID: 32437826 Free PMC article. Review.
• Diverse origins of the myofibroblast—implications for kidney fibrosis.
  Falke LL, Gholizadeh S, Goldschmeding R, Kok RJ, Nguyen TQ. Falke LL, et al. Nat Rev Nephrol. 2015 Apr;11(4):233-44. doi: 10.1038/nrneph.2014.246. Epub 2015 Jan 13. Nat Rev Nephrol. 2015. PMID: 25584804 Review.
• Targeting the epithelial cells in fibrosis: a new concept for an old disease.
  Moll S, Chaykovska L, Meier M, Budd DC, Formentini I, Pomposiello S, Prunotto M. Moll S, et al. Drug Discov Today. 2013 Jun;18(11-12):582-91. doi: 10.1016/j.drudis.2013.01.006. Epub 2013 Jan 22. Drug Discov Today. 2013. PMID: 23348679 Review.

Cited by

• The myofibroblast, biological activities and roles in eye repair and fibrosis. A focus on healing mechanisms in avascular cornea.
  Rocher M, Robert PY, Desmoulière A. Rocher M, et al. Eye (Lond). 2020 Feb;34(2):232-240. doi: 10.1038/s41433-019-0684-8. Epub 2019 Nov 25. Eye (Lond). 2020. PMID: 31767967 Free PMC article.
• Role of the Hippo Pathway in Fibrosis and Cancer.
  Kim CL, Choi SH, Mo JS. Kim CL, et al. Cells. 2019 May 16;8(5):468. doi: 10.3390/cells8050468. Cells. 2019. PMID: 31100975 Free PMC article. Review.
• Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
  Lima JDCC, Simoes E, de Castro G, Morais MRPT, de Matos-Neto EM, Alves MJ, Pinto NI, Figueredo RG, Zorn TMT, Felipe-Silva AS, Tokeshi F, Otoch JP, Alcantara P, Cabral FJ, Ferro ES, Laviano A, Seelaender M. Lima JDCC, et al. J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1045-1059. doi: 10.1002/jcsm.12441. Epub 2019 Jul 4. J Cachexia Sarcopenia Muscle. 2019. PMID: 31273954 Free PMC article.
• Reversal of pancreatic desmoplasia by a tumour stroma-targeted nitric oxide nanogel overcomes TRAIL resistance in pancreatic tumours.
  Huang HC, Sung YC, Li CP, Wan D, Chao PH, Tseng YT, Liao BW, Cheng HT, Hsu FF, Huang CC, Chen YT, Liao YH, Hsieh HT, Shih YC, Liu IJ, Wu HC, Lu TT, Wang J, Chen Y. Huang HC, et al. Gut. 2022 Sep;71(9):1843-1855. doi: 10.1136/gutjnl-2021-325180. Epub 2021 Dec 17. Gut. 2022. PMID: 34921062 Free PMC article.
• A 3D culture system for evaluating the combined effects of cisplatin and anti-fibrotic drugs on the growth and invasion of lung cancer cells co-cultured with fibroblasts.
  Pan HJ, Lee CW, Wu LY, Hsu HH, Tung YC, Liao WY, Lee CH. Pan HJ, et al. APL Bioeng. 2023 Mar 28;7(1):016117. doi: 10.1063/5.0115464. eCollection 2023 Mar. APL Bioeng. 2023. PMID: 37006781 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations